| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5616346 | SALIX PHARMS | Non-aqueous colonic purgative formulations |
May, 2013
(10 years ago) | |
Visicol is owned by Salix Pharms.
Visicol contains Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate.
Visicol has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Visicol are:
- US5616346
Visicol was authorised for market use on 21 September, 2000.
Visicol is available in tablet;oral dosage forms.
Visicol can be used as method of use of visicol.
The generics of Visicol are possible to be released after 18 May, 2013.
Market Authorisation Date: 21 September, 2000
Treatment: Method of use of visicol
Dosage: TABLET;ORAL
More Information on Dosage
VISICOL family patents
